Zobrazeno 1 - 10
of 21
pro vyhledávání: '"IA Calvo"'
Autor:
D Lara-Astiaso, A Goñi-Salaverri, J Mendieta-Esteban, N Narayan, C Del Valle, T Gross, G Giotopoulos, M Navarro-Alonso, J Zazpe, F Marchese, N Torrea, IA Calvo, C Lopez, D Alignani, A Lopez, B Saez, J. P Taylor-King, F Prosper, N Fortelny, B. J. P Huntly
Interactions between transcription factors (TF) and chromatin factors (CF) regulate gene expression programmes to determine cellular fate. However, unlike for TF, the exact role of CF in this process is poorly understood. Using haematopoiesis as a mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::920128c8094138451cdf409b7d002b26
https://doi.org/10.1101/2022.08.11.503571
https://doi.org/10.1101/2022.08.11.503571
Autor:
Lara-Astiaso D; Department of Haematology, University of Cambridge, Cambridge, UK. dl627@cam.ac.uk.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK. dl627@cam.ac.uk., Goñi-Salaverri A; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Mendieta-Esteban J; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Narayan N; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Del Valle C; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Gross T; Relation Therapeutics, London, UK., Giotopoulos G; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Beinortas T; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Navarro-Alonso M; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Aguado-Alvaro LP; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Zazpe J; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Marchese F; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Torrea N; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Calvo IA; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Lopez CK; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Alignani D; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Lopez A; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Saez B; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Taylor-King JP; Relation Therapeutics, London, UK., Prosper F; Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Fortelny N; Department of Biosciences & Medical Biology, University of Salzburg, Salzburg, Austria. nikolaus.fortelny@plus.ac.at., Huntly BJP; Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK. bjph2@cam.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2023 Sep; Vol. 55 (9), pp. 1542-1554. Date of Electronic Publication: 2023 Aug 14.
Autor:
Viñado AC; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Calvo IA; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Cenzano I; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., Olaverri D; Tecnun Universidad de Navarra, School of Engineering, 20018, San Sebastian, Spain., Cocera M; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., San Martin-Uriz P; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., Romero JP; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., Vilas-Zornoza A; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., Vera L; Regenerative Medicine Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., Gomez-Cebrian N; Drug Discovery Unit, Instituto de Investigación Sanitaria La Fe, 46026, Valencia, Spain., Puchades-Carrasco L; Drug Discovery Unit, Instituto de Investigación Sanitaria La Fe, 46026, Valencia, Spain., Lisi-Vega LE; Wellcome-MRC Cambridge Stem Cell Institute, Department of Hematology, University of Cambridge, and NHS Blood and Transplant, Cambridge, CB2 0AW, UK., Apaolaza I; Tecnun Universidad de Navarra, School of Engineering, 20018, San Sebastian, Spain.; Universidad de Navarra, Centro de Ingeniería Biomédica and DATAI Instituto de Ciencia de los Datos e Inteligencia Artificial, 31008, Pamplona, Spain., Valera P; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., Guruceaga E; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain., Granero-Molto F; Regenerative Medicine Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain.; Cell Therapy Area, Clínica Universidad de Navarra, 31008, Pamplona, Spain.; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 31008, Pamplona, Spain., Ripalda-Cemborain P; Regenerative Medicine Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain.; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 31008, Pamplona, Spain., Luck TJ; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Bullinger L; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Planes FJ; Tecnun Universidad de Navarra, School of Engineering, 20018, San Sebastian, Spain.; Universidad de Navarra, Centro de Ingeniería Biomédica and DATAI Instituto de Ciencia de los Datos e Inteligencia Artificial, 31008, Pamplona, Spain., Rifon JJ; Department of Hematology, Cell Therapy and Center of Cancer of the University of Navarra, Clínica Universidad de Navarra (CCUN), 31008, Pamplona, Spain., Méndez-Ferrer S; Wellcome-MRC Cambridge Stem Cell Institute, Department of Hematology, University of Cambridge, and NHS Blood and Transplant, Cambridge, CB2 0AW, UK., Yusuf RZ; Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA., Pardo-Saganta A; Institute for Lung Health (ILH), Justus Liebig University Giessen, Giessen, 35392, Germany.; Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, 35392, Germany.; German Center for Lung Research (DZL), Giessen, 35392, Germany., Prosper F; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain.; Department of Hematology, Cell Therapy and Center of Cancer of the University of Navarra, Clínica Universidad de Navarra (CCUN), 31008, Pamplona, Spain., Saez B; Hematology-Oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain. bsaezoch@unav.es.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain. bsaezoch@unav.es.
Publikováno v:
Leukemia [Leukemia] 2022 Aug; Vol. 36 (8), pp. 1969-1979. Date of Electronic Publication: 2022 May 26.
Autor:
Ye J; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia., Calvo IA; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Cenzano I; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain., Vilas A; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Martinez-de-Morentin X; Navarrabiomed, ComplejoHospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, 31008 Navarra, Spain., Lasaga M; Navarrabiomed, ComplejoHospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, 31008 Navarra, Spain., Alignani D; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Paiva B; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Viñado AC; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., San Martin-Uriz P; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain., Romero JP; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain., Quilez Agreda D; Hospital Reina Sofía de Tudela, 31500 Navarra, Spain., Miñana Barrios M; Hospital Reina Sofía de Tudela, 31500 Navarra, Spain., Sancho-González I; Hospital Reina Sofía de Tudela, 31500 Navarra, Spain., Todisco G; Department of Molecular Medicine, University of Pavia & Unit of Precision Hematology Oncology, IRCCS S. Matteo Hospital Foundation, 27100 Pavia, Italy.; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, 17177 Stockholm, Sweden., Malcovati L; Department of Molecular Medicine, University of Pavia & Unit of Precision Hematology Oncology, IRCCS S. Matteo Hospital Foundation, 27100 Pavia, Italy., Planell N; Navarrabiomed, ComplejoHospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, 31008 Navarra, Spain., Saez B; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Tegner JN; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, 17177 Stockholm, Stockholm, Sweden.; Computer, Electrical, and Mathematical Sciences and Engineering Division (CEMSE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Bioengineering Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia., Prosper F; Universidad de Navarra, CIMA, Hematology-Oncology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain.; Service of Hematology and Cell Therapy, Clínica Universidad de Navarra; CCUN, Pamplona, Navarra, 31008; Spain., Gomez-Cabrero D; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Navarrabiomed, ComplejoHospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, 31008 Navarra, Spain.; Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, 17177 Stockholm, Stockholm, Sweden.; Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College, London WC2R 2LS, UK.; Bioengineering Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.
Publikováno v:
IScience [iScience] 2022 Apr 08; Vol. 25 (5), pp. 104225. Date of Electronic Publication: 2022 Apr 08 (Print Publication: 2022).
Autor:
Valdés-Fernández J; Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain., López-Martínez T; Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain., Ripalda-Cemboráin P; Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, Pamplona, Spain., Calvo IA; Hematology-Oncology Program, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Sáez B; Hematology-Oncology Program, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Romero-Torrecilla JA; Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain., Aldazabal J; Tissue Engineering Group, TECNUN-Universidad de Navarra, San Sebastián, Spain., Muiños-López E; Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain., Montiel V; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, Pamplona, Spain., Orbe J; Atherotrombosis, Cardiovascular Disease Program, CIMA, Instituto de Investigación Sanitaria de Navarra (IdiSNA), CIBERCV, Pamplona, Spain., Rodríguez JA; Atherotrombosis, Cardiovascular Disease Program, CIMA, Instituto de Investigación Sanitaria de Navarra (IdiSNA), CIBERCV, Pamplona, Spain., Páramo JA; Atherotrombosis, Cardiovascular Disease Program, CIMA, Instituto de Investigación Sanitaria de Navarra (IdiSNA), CIBERCV, Pamplona, Spain.; Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain., Prósper F; Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain.; Hematology-Oncology Program, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain., Granero-Moltó F; Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, Pamplona, Spain.
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2021 Nov; Vol. 36 (11), pp. 2203-2213. Date of Electronic Publication: 2021 Jul 06.
Autor:
Calvo IA; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA., Sharma S; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Gulka AOD; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA., Boeszoermenyi A; Department of Biochemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Dana-Farber Cancer Institute, Boston, MA 02215, USA., Zhang J; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA., Lombana JM; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA., Palmieri CM; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA., Laviolette LA; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA., Arthanari H; Department of Biochemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Dana-Farber Cancer Institute, Boston, MA 02215, USA., Iliopoulos O; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA.; Division of Hematology-Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Motamedi M; Massachusetts General Hospital Center for Cancer Research and Department of Medicine Harvard Medical School, Charlestown, MA 02129, USA.
Publikováno v:
IScience [iScience] 2021 Oct 23; Vol. 24 (11), pp. 103338. Date of Electronic Publication: 2021 Oct 23 (Print Publication: 2021).
Autor:
Vera L; Department of Regenerative Medicine and., Garcia-Olloqui P; Department of Regenerative Medicine and., Petri E; Department of Regenerative Medicine and., Viñado AC; Department of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain., Valera PS; Department of Regenerative Medicine and., Blasco-Iturri Z; Molecular and Functional Biomarkers Lab, Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), San Sebastián, Spain., Calvo IA; Department of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain., Cenzano I; Department of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain., Ruppert C; Biobank of the Universities of Giessen and Marburg Lung Center and the European Idiopathic Pulmonary Fibrosis Registry, German Center for Lung Research, Giessen, Germany; and., Zulueta JJ; Pulmonary Department, Clinica Universidad de Navarra, Pamplona, Spain., Prosper F; Department of Regenerative Medicine and.; Department of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain., Saez B; Department of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain., Pardo-Saganta A; Department of Regenerative Medicine and.
Publikováno v:
American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2021 Apr; Vol. 64 (4), pp. 465-476.
Autor:
Sanchez-Herrero A; Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Queensland 4059, Australia., Calvo IA; Centro de Investigación Médica Aplicada (CIMA), IDISNA-Instituto de Investigación Biosanitaria de Navarra, 31008 Pamplona, Spain.; Hematology-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Department of Hematology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., Flandes-Iparraguirre M; Centro de Investigación Médica Aplicada (CIMA), IDISNA-Instituto de Investigación Biosanitaria de Navarra, 31008 Pamplona, Spain.; Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain., Landgraf M; Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Queensland 4059, Australia., Lahr CA; Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Queensland 4059, Australia., Shafiee A; Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Queensland 4059, Australia.; Herston Biofabrication Institute, Metro North Hospital and Health Service, Brisbane 4029, Australia., Granero-Molto F; Centro de Investigación Médica Aplicada (CIMA), IDISNA-Instituto de Investigación Biosanitaria de Navarra, 31008 Pamplona, Spain.; Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain., Saez B; Centro de Investigación Médica Aplicada (CIMA), IDISNA-Instituto de Investigación Biosanitaria de Navarra, 31008 Pamplona, Spain.; Hematology-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain., Mazo MM; Centro de Investigación Médica Aplicada (CIMA), IDISNA-Instituto de Investigación Biosanitaria de Navarra, 31008 Pamplona, Spain.; Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain., Paiva B; Centro de Investigación Médica Aplicada (CIMA), IDISNA-Instituto de Investigación Biosanitaria de Navarra, 31008 Pamplona, Spain., de Juan Pardo E; Translational 3d Printing Laboratory for Advanced Tissue Engineering (T3mPLATE), Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and Centre for Medical Research, The University of Western Australia, Perth 6009, Australia.; School of Engineering, The University of Western Australia, Perth 6009, Australia.; School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane 4000, Queensland, Australia., Nicol A; University of Queensland, Greenslopes Private Hospital, Brisbane, QLD 4120, Australia., Prosper F; Centro de Investigación Médica Aplicada (CIMA), IDISNA-Instituto de Investigación Biosanitaria de Navarra, 31008 Pamplona, Spain.; Hematology-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Department of Hematology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain., Bray LJ; Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Queensland 4059, Australia.; School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane 4000, Queensland, Australia., McGovern JA; Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Queensland 4059, Australia.; School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane 4000, Queensland, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Aug 06; Vol. 12 (8). Date of Electronic Publication: 2020 Aug 06.
Autor:
Laviolette LA; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA., Mermoud J; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA., Calvo IA; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA., Olson N; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA., Boukhali M; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA., Steinlein OK; Institute of Human Genetics, University Hospital Munich, University of Munich, Munich 80336, Germany., Roider E; Department of Dermatology and Allergology, University Hospital, Ludwig Maximilian University Munich, Munich D-80337, Germany., Sattler EC; Department of Dermatology and Allergology, University Hospital, Ludwig Maximilian University Munich, Munich D-80337, Germany., Huang D; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore 169610, Singapore., Teh BT; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore 169610, Singapore., Motamedi M; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA., Haas W; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA., Iliopoulos O; Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02139, USA.; Division of Hematology-Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Publikováno v:
Nature communications [Nat Commun] 2017 Jun 28; Vol. 8, pp. 15866. Date of Electronic Publication: 2017 Jun 28.
Autor:
Joh RI; Massachusetts General Hospital Center for Cancer Research and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA., Khanduja JS; Massachusetts General Hospital Center for Cancer Research and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA., Calvo IA; Massachusetts General Hospital Center for Cancer Research and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA., Mistry M; Bioinformatics Core, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Palmieri CM; Massachusetts General Hospital Center for Cancer Research and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA., Savol AJ; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA., Ho Sui SJ; Bioinformatics Core, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Sadreyev RI; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Aryee MJ; Massachusetts General Hospital Center for Cancer Research and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Motamedi M; Massachusetts General Hospital Center for Cancer Research and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA. Electronic address: mmotamedi@hms.harvard.edu.
Publikováno v:
Molecular cell [Mol Cell] 2016 Dec 15; Vol. 64 (6), pp. 1088-1101.